跳至主要内容
临床试验/NCT04121806
NCT04121806招募中不适用

Diet Intervention as a Prebiotic Treatment for Active Ulcerative Colitis

Mount Sinai Hospital, Canada2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
2
主要终点
Change in microbiome composition

研究概览

简要总结

The purpose of this study is to determine if a sustainable non-elemental diet can be used as a probiotic tool to alter the dysbiotic microbiome found in individuals with ulcerative colitis and thereby decrease disease activity.

详细描述

The etiology of inflammatory bowel disease (IBD), including ulcerative colitis (UC), is complex and poorly understood, but the current hypothesis is that IBD arises from an aberrant immune response to commensal bacteria in a genetically susceptible host, and is triggered by environmental factors. Environmental factors such as the microbiome and diet, play a significant role in the risk of IBD. Diet has been identified as one of the main drivers of the microbiome composition and the microbiome and diet can work in tandem to affect host physiology.

In spite of patient interest in diet and numerous diet studies, currently there is no diet that is clinically validated or universally agreed upon for adult IBD patients. We also lack rigorous studies to show how the microbiome is influenced by diet and affects patient outcomes.

We propose to use a sustainable non-elemental diet aimed at altering the microbiome in patients with mild to moderately active UC to alter their disease activity.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •• Females and Males between the ages of 18 - 75 years of age at the time of enrolment
  • •Must have established diagnosis of UC by standard endoscopic, radiographic, or histological criteria
  • •Must have active UC defined by having a Mayo score equal to or greater than 2 within two months prior to enrollment
  • •Must have had > 10cm involvement at some point in their disease history
  • •FCP>250 or active endo within 6 months
  • •If a smoker, must not change smoking habits (frequency) during the course of the study
  • •If receiving medical therapy, no baseline therapy change within 4 weeks of study initiation and no change during the course of the study

排除标准

  • •• Uncontrolled inflammation which will likely require surgery or escalation of therapy within 4 weeks of enrollment
  • •Pregnant or lactating females
  • •Allergy or intolerance to key or a great number food components of the study diet
  • •Current NSAID use
  • •Diagnosed with PSC
  • •Using topical therapies or suppositories
  • •Antibiotic use within 4 weeks of the study enrollment or during the study
  • •Confirmed C. difficile infection within 3 months of recruitment;
  • •Diagnosis of primary PSC;
  • •Currently using topical therapies or suppositories
  • •History of dysplasia or colorectal neoplasia.

研究组 & 干预措施

Ulcerative colitis patients with mild to moderate activity

Experimental

Participants will be followed for 14 days on their traditional diet followed by an 8 week intervention with the specially designed and provided treatment diet.

干预措施: UC intervention diet (Other)

结局指标

主要结局

Change in microbiome composition

时间窗: 10 weeks

measured by 16S rDNA sequencing and comparing pretreatment diet and the treatment diet within an individual

Change in microbiome function

时间窗: 10 weeks

measured by shotgun sequencing and comparing difference in enriched functional pathways between pretreatment diet and the treatment diet within an individual

次要结局

  • Decrease in endoscopic disease activity(10 weeks)
  • Decrease in clinical disease activity(10 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验